1834 Investment Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

1834 Investment Advisors’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1	Closed	–	–	464
2020 Q4	$0	Hold	1	–	–	﹤0.01%	459
2020 Q3	$0	Hold	1	–	–	﹤0.01%	418
2020 Q2	$0	Hold	1	–	–	﹤0.01%	449
2020 Q1	$0	Hold	1	–	–	﹤0.01%	400
2019 Q4	$0	Hold	1	–	–	﹤0.01%	452
2019 Q3	$0	Hold	1	–	–	﹤0.01%	457
2019 Q2	$0	Hold	1	–	–	﹤0.01%	430
2019 Q1	$0	Hold	1	–	–	﹤0.01%	410
2018 Q4	$0	Hold	1	–	–	﹤0.01%	404
2018 Q3	$0	Hold	1	–	–	﹤0.01%	400
2018 Q2	$0	Sell	1 -1	-50%	-$62	﹤0.01%	417
2018 Q1	$0	Hold	2	–	–	﹤0.01%	444
2017 Q4	$0	Buy	+2	New	+$124	﹤0.01%	454

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ICOM

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return

1834 Investment Advisors's ANIP Position: Q1 2021 in Review

1834 Investment Advisors sold out of ANI Pharmaceuticals (ANIP) in Q1 2021, closing a stake of 1 share.

1834 Investment Advisors first reported a position in ANIP in Q4 2017 and held it in 13 quarters. The position peaked at $0 in Q4 2020. 106 funds tracked by Wall St. Rank hold ANIP as of Q1 2021.

1834 Investment Advisors reported no remaining ANI Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
1834 Investment Advisors sold 1 ANI Pharmaceuticals share in Q1 2021.
1834 Investment Advisors first reported a position in ANI Pharmaceuticals in Q4 2017 and held it in 13 quarters.
1834 Investment Advisors's ANI Pharmaceuticals position peaked at $0 in Q4 2020.
106 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2021.

Based on 1834 Investment Advisors's 13F filing for Q1 2021, filed 14 May 2021.